Lion Point Capital »

Benitec Biopharma shares owned by Lion Point Capital

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Benitec Biopharma

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 29400k500k600k700k800k40k45k50k55k60k
Value ($)Share countHistorical BNTC position of Lion Point Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $783k 62k 12.63
2024-09-30 $358k 39k 9.19

More positions owned by Lion Point Capital

Insmed Com Par $.01 (INSM)
Milestone Pharmaceuticals (MIST)
Geron Corporation (GERN)
Ardelyx (ARDX)
Fennec Pharmaceuticals (FENC)
Bridgebio Pharma (BBIO)
Mineralys Therapeutics (MLYS)
Kiniksa Pharmaceuticals Ord Shs Cl A (KNSA)
Biohaven (BHVN)
Benitec Biopharma Com New (BNTC)
Syndax Pharmaceuticals (SNDX)
Jasper Therapeutics Com New (JSPR)
Avadel Pharmaceuticals Com Shs (AVDL)
Disc Medicine (IRON)
Bluebird Bio Com New (BLUE)

View all positions for Lion Point Capital

Top funds holding Benitec Biopharma

Suvretta Capital Management
Franklin Resources
Henderson Group
Adage Capital Partners GP
Nantahala Capital Management
Vanguard Group
Schonfeld Strategic Advisors
Infinitum Asset Management
Geode Capital Management
BlackRock
AWM Investment Company
Simplify Asset Management
Lion Point Capital
MYDA Advisors
Morgan Stanley

View all funds holding Benitec Biopharma